Maxtra P Syrup

Description

Maxtra P Syrup is a combination medication used to alleviate symptoms associated with the common cold, allergic rhinitis, and other upper respiratory tract allergies in children.

Composition

Each 5 ml of Maxtra P Syrup contains:

• Paracetamol – 125 mg

• Phenylephrine – 5 mg

• Chlorpheniramine Maleate – 1 mg

These active ingredients work synergistically to provide relief from various symptoms:

• Paracetamol acts as an analgesic and antipyretic, reducing pain and fever.

• Phenylephrine is a nasal decongestant that narrows blood vessels in the nasal passages, reducing swelling and congestion.

• Chlorpheniramine Maleate is an antihistamine that alleviates allergy symptoms such as sneezing, runny nose, and itchy/watery eyes.

Uses

Maxtra P Syrup is primarily used for:

• Relieving symptoms of the common cold

• Alleviating symptoms of allergic rhinitis (hay fever)

• Managing other upper respiratory tract allergies

• Providing relief from nasal congestion, sneezing, and watery eyes

Side Effects

While Maxtra P Syrup is generally well-tolerated, some individuals may experience side effects, including:

• Drowsiness or sedation

• Dry mouth, nose, or throat

• Blurred vision

• Difficulty urinating

• Constipation

• Nausea and vomiting

• Increased heart rate (tachycardia)

These side effects are typically mild and may resolve as the body adjusts to the medication. However, if any side effects persist or worsen, it is important to consult a healthcare professional.

Precautions

• Pregnancy: Use during pregnancy should be under medical supervision, as the safety of Maxtra P Syrup during pregnancy has not been fully established.

• Breastfeeding: Consult a healthcare provider before using Maxtra P Syrup while breastfeeding.

• Liver and Kidney Function: Individuals with liver or kidney impairments should use Maxtra P Syrup with caution and under medical guidance.

• Drug Interactions: Inform your doctor about any other medications you are taking to avoid potential drug interactions.